XML 75 R2.htm IDEA: XBRL DOCUMENT

Pay vs Performance Disclosure - USD ($)

12 Months Ended

Dec. 31, 2025

Dec. 31, 2024

Dec. 31, 2023

Dec. 31, 2022

Dec. 31, 2021

Pay vs Performance Disclosure

Pay vs Performance Disclosure, Table


							Value of Initial Fixed $100 Investment Based On

Year	Summary Compensation Table Total for Former CEO ($)	Summary Compensation Table Total for Current CEO ($)	Compensation Actually Paid to Former CEO(4) ($)	Compensation Actually Paid to Current CEO(4) ($)	Average Summary Compensation Table Total for non-CEO NEOs ($)	Average Compensation Actually Paid to non-CEO NEOs(4) ($)	Total Shareholder Return(5) ($)	Peer Group Total Shareholder Return(5) ($)	Net Income (in Millions) (GAAP)(6) ($)	Total Revenues (in Millions)(7) ($)

2025(1)		21,879,919		16,862,134	9,221,260	7,316,487	105	198	7,054	48,194
2024(2)		18,787,618		21,204,985	7,717,989	8,945,524	105	154	(8,948)	48,300
2023(3)	19,661,434	8,461,833	(6,907,611)	382,568	5,917,907	(525,203)	91	142	8,025	45,006
2022(4)	20,053,032		35,057,807		6,996,472	10,872,377	123	139	6,327	46,159
2021(4)	19,784,806		16,505,622		7,140,446	6,780,078	103	126	6,994	46,385

Company Selected Measure Name

total revenues

Named Executive Officers, Footnote

The NEOs for 2025 are Dr. Chris Boerner (CEO), Mr. David Elkins, Dr. Cristian Massacesi, Mr. Adam Lenkowsky, Mr. Greg Meyers, and Dr. Samit Hirawat.

(2)The NEOs for 2024 are Dr. Chris Boerner, Mr. David Elkins, Dr. Samit Hirawat, Ms. Sandra Leung and Ms. Karin Shanahan.

(3)The NEOs for 2023 are Dr. Giovanni Caforio (Former CEO), Dr. Chris Boerner (Current CEO), Mr. David Elkins, Dr. Samit Hirawat, Ms. Sandra Leung and Ms. Elizabeth Mily.

(4)The NEOs for years 2021-2022 are Dr. Giovanni Caforio (CEO), Dr. Chris Boerner, Mr. David Elkins, Dr. Rupert Vessey and Ms. Sandra Leung.

Peer Group Issuers, Footnote

The Company TSR and the Peer Group TSR reflected in these columns for each of the applicable fiscal years is calculated based on a fixed investment of $100 at the applicable measurement point on the same cumulative basis as is used in Item 201(e) of Regulation S-K. The peer group used to determine the Company’s Peer Group TSR for 2025 is the extended peer group that was used for purposes of disclosing our executive compensation benchmarking practices, as described in the section titled “Benchmarking Analysis and Compensation Peer Groups” on page 53 and also as disclosed in our Annual Report on Form 10-K pursuant to Item 201(e) of Regulation S-K for these years. The extended peer group is composed of AbbVie Inc., Amgen Inc., Eli Lilly and Company, Gilead Sciences Inc., Johnson & Johnson, Merck & Co., Pfizer Inc., Regeneron Pharmaceuticals, AstraZeneca PLC, GlaxoSmithKline PLC, Roche Holding AG, Novartis AG, and Sanofi. The extended peer group for fiscal years 2021-2024 was composed of AbbVie Inc., Amgen Inc., Biogen Inc., Eli Lilly and Company, Gilead Sciences Inc., Johnson & Johnson, Merck & Co., Pfizer Inc., AstraZeneca PLC, GlaxoSmithKline PLC, Roche Holding AG, Novartis AG, and Sanofi.

PEO Total Compensation Amount

$ 21,879,919

$ 18,787,618

$ 20,053,032

$ 19,784,806

PEO Actually Paid Compensation Amount

$ 16,862,134

21,204,985

35,057,807

16,505,622

Adjustment To PEO Compensation, Footnote

CAP reflects the total compensation reported in the 2025 SCT for the years ended December 31, 2025, 2024, 2023 and 2023 SCT for the years ended 2022 and 2021, in each case, adjusted to include or exclude the amounts shown in the tables below for the NEOs. To calculate CAP, the following amounts were deducted from and added to SCT total compensation, computed in accordance with Item 402(v) of Regulation S-K:

Former CEO SCT Total to CAP Reconciliation


Year	SCT Total for Former CEO ($)	Deduction of Change in Pension Values for Former CEO(a) ($)	Deduction of Stock Awards and Options Values for Former CEO(b) ($)	Addition of Pension Service Cost for Former CEO(c) ($)	Addition of Equity Values for Former CEO(d)* ($)	Compensation Actually Paid for Former CEO ($)

2023	19,661,434	0	(14,465,570)	0	(12,103,475)	(6,907,611)
2022	20,053,032	0	(14,289,505)	0	29,294,280	35,057,807
2021	19,784,806	0	(13,965,989)	0	10,686,805	16,505,622

Current CEO SCT Total to CAP Reconciliation


Year	SCT Total for Current CEO ($)	Deduction of Change in Pension Values for Current CEO(a) ($)	Deduction of Stock Awards and Options Values for Current CEO(b) ($)	Addition of Pension Service Cost for Current CEO(c) ($)	Addition of Equity Values for Current CEO(d)* ($)	Compensation Actually Paid for Current CEO ($)

2025	21,879,919	0	(16,061,399)	0	11,043,614	16,862,134
2024	18,787,618	0	(13,643,063)	0	16,060,430	21,204,985
2023	8,461,833	0	(5,326,178)	0	(2,753,087)	382,568

Average non-CEO Named Executive Officers SCT Total to CAP Reconciliation


Year	SCT Total ($)	Deduction of Change in Pension Values(a) ($)	Deduction of Stock Awards and Options Values(b) ($)	Addition of Pension Service Cost(c) ($)	Addition of Equity Values(d)* ($)	Compensation Actually Paid ($)

2025	9,221,260	(5,412)	(5,999,359)	0	4,099,998	7,316,487
2024	7,717,989	0	(4,875,280)	0	6,102,814	8,945,524
2023	5,917,907	0	(3,525,996)	0	(2,917,115)	(525,203)
2022	6,996,472	0	(4,304,359)	0	8,180,264	10,872,377
2021	7,140,446	0	(4,208,611)	0	3,848,242	6,780,078

(a)Represents change in pension value under the BEP-RIP reported in the SCT for each year shown. See the footnotes to the 2025 and 2023 SCTs for further detail regarding the amounts in this column.

(b)Represents the grant date fair value of equity-based awards granted each year and reported in the SCT for each year shown. See the footnotes to the 2025 and 2023 SCTs for further detail regarding the amounts in this column.

(c)Does not include any service cost for pension benefits under the U.S BEP-RIP as the plan was frozen in 2009 and, therefore, there is no service cost. The company terminated the US-RIP as of February 1, 2019.

(d)Reflects the value of equity calculated in accordance with the SEC methodology for determining the compensation actually paid for each year shown.

*The amounts in the Addition of Equity Values in the tables above are derived from the amounts set forth in the following table:


	Year-End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year ($)	Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards ($)	Vesting-Date Fair Value of Equity Awards Granted During Year that Vested During Year ($)	Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year ($)	Fair Value at Last Day of Prior Year of Equity Awards Forfeited During Year ($)	Value of Dividends or Other Earnings Paid on Stock or Option Awards Not Otherwise Included ($)	Total - Addition of Equity Values ($)

Former CEO
2023	4,874,459	(16,751,751)	0	(226,183)	0	0	(12,103,475)
2022	15,604,262	7,721,151	0	5,968,867	0	0	29,294,280
2021	13,701,811	(2,650,377)	0	(364,629)	0	0	10,686,805
Current CEO
2025	13,242,470	(2,506,633)	0	307,776	0	0	11,043,614
2024	14,640,099	1,437,395	0	(17,064)	0	0	16,060,430
2023	2,266,251	(4,900,396)	0	(118,943)	0	0	(2,753,087)
Average of Non-CEO NEOs
2025	4,990,570	(499,641)	175,232	110,049	(676,212)	0	4,099,998
2024	5,246,975	903,799	0	(47,959)	0	0	6,102,814
2023	1,188,161	(4,033,124)	0	(72,151)	0	0	(2,917,115)
2022	4,700,394	2,222,732	0	1,201,754	0	55,384	8,180,264
2021	4,128,997	(478,162)	0	25,413	0	171,994	3,848,242

Non-PEO NEO Average Total Compensation Amount

$ 9,221,260

7,717,989

$ 5,917,907

6,996,472

7,140,446

Non-PEO NEO Average Compensation Actually Paid Amount

$ 7,316,487

8,945,524

(525,203)

10,872,377

6,780,078

Adjustment to Non-PEO NEO Compensation Footnote

Former CEO SCT Total to CAP Reconciliation


Year	SCT Total for Former CEO ($)	Deduction of Change in Pension Values for Former CEO(a) ($)	Deduction of Stock Awards and Options Values for Former CEO(b) ($)	Addition of Pension Service Cost for Former CEO(c) ($)	Addition of Equity Values for Former CEO(d)* ($)	Compensation Actually Paid for Former CEO ($)

2023	19,661,434	0	(14,465,570)	0	(12,103,475)	(6,907,611)
2022	20,053,032	0	(14,289,505)	0	29,294,280	35,057,807
2021	19,784,806	0	(13,965,989)	0	10,686,805	16,505,622

Current CEO SCT Total to CAP Reconciliation


Year	SCT Total for Current CEO ($)	Deduction of Change in Pension Values for Current CEO(a) ($)	Deduction of Stock Awards and Options Values for Current CEO(b) ($)	Addition of Pension Service Cost for Current CEO(c) ($)	Addition of Equity Values for Current CEO(d)* ($)	Compensation Actually Paid for Current CEO ($)

2025	21,879,919	0	(16,061,399)	0	11,043,614	16,862,134
2024	18,787,618	0	(13,643,063)	0	16,060,430	21,204,985
2023	8,461,833	0	(5,326,178)	0	(2,753,087)	382,568

Average non-CEO Named Executive Officers SCT Total to CAP Reconciliation


Year	SCT Total ($)	Deduction of Change in Pension Values(a) ($)	Deduction of Stock Awards and Options Values(b) ($)	Addition of Pension Service Cost(c) ($)	Addition of Equity Values(d)* ($)	Compensation Actually Paid ($)

2025	9,221,260	(5,412)	(5,999,359)	0	4,099,998	7,316,487
2024	7,717,989	0	(4,875,280)	0	6,102,814	8,945,524
2023	5,917,907	0	(3,525,996)	0	(2,917,115)	(525,203)
2022	6,996,472	0	(4,304,359)	0	8,180,264	10,872,377
2021	7,140,446	0	(4,208,611)	0	3,848,242	6,780,078

(a)Represents change in pension value under the BEP-RIP reported in the SCT for each year shown. See the footnotes to the 2025 and 2023 SCTs for further detail regarding the amounts in this column.

(d)Reflects the value of equity calculated in accordance with the SEC methodology for determining the compensation actually paid for each year shown.

*The amounts in the Addition of Equity Values in the tables above are derived from the amounts set forth in the following table:


	Year-End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year ($)	Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards ($)	Vesting-Date Fair Value of Equity Awards Granted During Year that Vested During Year ($)	Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year ($)	Fair Value at Last Day of Prior Year of Equity Awards Forfeited During Year ($)	Value of Dividends or Other Earnings Paid on Stock or Option Awards Not Otherwise Included ($)	Total - Addition of Equity Values ($)

Former CEO
2023	4,874,459	(16,751,751)	0	(226,183)	0	0	(12,103,475)
2022	15,604,262	7,721,151	0	5,968,867	0	0	29,294,280
2021	13,701,811	(2,650,377)	0	(364,629)	0	0	10,686,805
Current CEO
2025	13,242,470	(2,506,633)	0	307,776	0	0	11,043,614
2024	14,640,099	1,437,395	0	(17,064)	0	0	16,060,430
2023	2,266,251	(4,900,396)	0	(118,943)	0	0	(2,753,087)
Average of Non-CEO NEOs
2025	4,990,570	(499,641)	175,232	110,049	(676,212)	0	4,099,998
2024	5,246,975	903,799	0	(47,959)	0	0	6,102,814
2023	1,188,161	(4,033,124)	0	(72,151)	0	0	(2,917,115)
2022	4,700,394	2,222,732	0	1,201,754	0	55,384	8,180,264
2021	4,128,997	(478,162)	0	25,413	0	171,994	3,848,242

Compensation Actually Paid vs. Total Shareholder Return

CAP and Company TSR

CAP over the last five years is closely aligned with the Company’s TSR performance as presented in the chart below. This is because a significant portion of CAP is comprised of equity awards. As described in more detail in the section titled “2025 Target Compensation Benchmarks,” approximately 80% of the CEO’s 2025 target compensation and, on average, 70% of the non-CEO Named Executive Officers’ 2025 target compensation is comprised of equity awards delivered in MSUs and PSUs, tied to absolute and relative stock price performance in addition to financial performance.

The Company’s TSR over the 5-year period ending December 31, 2025 was 4.8%, while the Company’s peer group TSR was 98.4% for the same period of time.

Compensation Actually Paid vs. Net Income

CAP and Net Income

The Company’s net income and CAP have varied each year. The Company does not use net income as a performance metric in the annual and long-term incentive plans, and CAP is not meaningfully correlated with the company’s net income (GAAP).

Compensation Actually Paid vs. Company Selected Measure

CAP and Total Revenues

CAP is generally aligned with the Company’s total revenues over the five years. While the Company uses various financial and non-financial performance measures for the purpose of evaluating performance for the Company’s compensation programs, the Company has determined that total revenues is the Company’s most important financial performance measure (that is not otherwise required to be disclosed in the table) used to link Named Executive Officer CAP to company performance for fiscal year 2025. The Company utilizes revenue as a performance metric for the Company’s annual incentive program and PSU awards granted to the Named Executive Officers in the long-term incentive program. As described in more detail in the section titled “Executive Compensation Program Overview” on page 50, 35% of annual incentives and 40% of the PSUs for 2025 were based on achieving revenue goals for our Growth Portfolio Revenue.

Tabular List, Table

Significant Financial and Non-Financial Performance Measures

Revenue

SSI Scorecard

Pipeline

Stock Price

Operating Income

Relative TSR

Total Shareholder Return Amount

$ 105

105

123

103

Peer Group Total Shareholder Return Amount

198

154

142

139

126

Net Income (Loss)

$ 7,054,000,000

$ (8,948,000,000)

$ 8,025,000,000

$ 6,327,000,000

$ 6,994,000,000

Company Selected Measure Amount

48,194,000,000

48,300,000,000

45,006,000,000

46,159,000,000

46,385,000,000

Additional 402(v) Disclosure

Net income is equivalent to “Net Earnings/(Loss) Attributable to BMS” as reported in the Company’s consolidated financial statements.

(8)SEC rules require us to designate a “Company-Selected Measure” that in our assessment represents the most important financial performance measure used by the Company to link the CAP of our Named Executive Officers, for the most recently completed fiscal year, to our performance. We have selected total revenues as this measure for fiscal year 2025.

Measure:: 1

Pay vs Performance Disclosure

Name

Revenue

Measure:: 2

Pay vs Performance Disclosure

Name

Operating Income

Measure:: 3

Pay vs Performance Disclosure

Name

SSI Scorecard